These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8989819)

  • 21. Effect of a synthetic carboxy-terminal peptide of alpha(2)-antiplasmin on urokinase-induced fibrinolysis.
    Lee KN; Jackson KW; McKee PA
    Thromb Res; 2002 Feb; 105(3):263-70. PubMed ID: 11927133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-linking of fibronectin to collagen by blood coagulation Factor XIIIa.
    Mosher DF; Schad PE
    J Clin Invest; 1979 Sep; 64(3):781-7. PubMed ID: 38260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the cross-linking patterns of lamprey fibrinogen and fibrin by the action of the intrinsic lamprey factor XIII and human factor XIII during the process of blood coagulation.
    Murtaugh PA
    Thromb Haemost; 1977 Aug; 38(2):429-37. PubMed ID: 579486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrin-fibrin and alpha 2-antiplasmin-fibrin cross-linking by platelet factor XIII increases the resistance of platelet clots to fibrinolysis.
    Reed GL; Matsueda GR; Haber E
    Trans Assoc Am Physicians; 1991; 104():21-8. PubMed ID: 1845147
    [No Abstract]   [Full Text] [Related]  

  • 25. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Functional characterization of a monoclonal antibody which interferes with the binding of t-PA to fibrin].
    Orbe J; Montes R; Chordá C; Páramo JA; Rocha E
    Sangre (Barc); 1994 Aug; 39(4):261-6. PubMed ID: 7985055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors that control extravascular fibrinolysis.
    Chung SI; Lee SY; Uchino R; Carmassi F
    Semin Thromb Hemost; 1996; 22(6):479-88. PubMed ID: 9122712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human complement C3 is a substrate for transglutaminases. A functional link between non-protease-based members of the coagulation and complement cascades.
    Nikolajsen CL; Scavenius C; Enghild JJ
    Biochemistry; 2012 Jun; 51(23):4735-42. PubMed ID: 22630814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking.
    Byrnes JR; Duval C; Wang Y; Hansen CE; Ahn B; Mooberry MJ; Clark MA; Johnsen JM; Lord ST; Lam WA; Meijers JC; Ni H; Ariëns RA; Wolberg AS
    Blood; 2015 Oct; 126(16):1940-8. PubMed ID: 26324704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Covalent crosslinking of von Willebrand factor to fibrin.
    Hada M; Kaminski M; Bockenstedt P; McDonagh J
    Blood; 1986 Jul; 68(1):95-101. PubMed ID: 2872929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Fibrinolysis by Coagulation Factor XIII.
    Rijken DC; Uitte de Willige S
    Biomed Res Int; 2017; 2017():1209676. PubMed ID: 28761875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrin clot formation and lysis: basic mechanisms.
    Sidelmann JJ; Gram J; Jespersen J; Kluft C
    Semin Thromb Hemost; 2000; 26(6):605-18. PubMed ID: 11140797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of wild-type and mutant alpha2-antiplasmins: fibrinolysis enhancement by reactive site mutant.
    Lee KN; Tae WC; Jackson KW; Kwon SH; McKee PA
    Blood; 1999 Jul; 94(1):164-71. PubMed ID: 10381509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crosslinking of alpha 2-antiplasmin to fibrin.
    Lee KN; Lee CS; Tae WC; Jackson KW; Christiansen VJ; McKee PA
    Ann N Y Acad Sci; 2001; 936():335-9. PubMed ID: 11460490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progressive cross-linking of fibrin gamma chains increases resistance to fibrinolysis.
    Siebenlist KR; Mosesson MW
    J Biol Chem; 1994 Nov; 269(45):28414-9. PubMed ID: 7961782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factor XIIIa-derived peptides inhibit transglutaminase activity. Localization of substrate recognition sites.
    Achyuthan KE; Slaughter TF; Santiago MA; Enghild JJ; Greenberg CS
    J Biol Chem; 1993 Oct; 268(28):21284-92. PubMed ID: 8104938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The contribution of activated factor XIII to fibrinolytic resistance in experimental pulmonary embolism.
    Reed GL; Houng AK
    Circulation; 1999 Jan; 99(2):299-304. PubMed ID: 9892598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A unique factor XIII inhibitor to a fibrin-binding site on factor XIIIA.
    Fukue H; Anderson K; McPhedran P; Clyne L; McDonagh J
    Blood; 1992 Jan; 79(1):65-74. PubMed ID: 1370210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrinogen and factor XIII at the intersection of coagulation, fibrinolysis and inflammation.
    Hoppe B
    Thromb Haemost; 2014 Oct; 112(4):649-58. PubMed ID: 25182841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immobilization of soluble fibrin on factor XIIIa-coated polystyrene beads mediated by N-terminal fibronectin fragments. II. Demonstration of covalent adducts of fibrin peptide chains and fibronectin fragments.
    Hörmann H; Richter H; Jelinić V
    Biol Chem Hoppe Seyler; 1991 Jun; 372(6):427-30. PubMed ID: 1680341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.